SORRENTO THERAPEUTICS, INC. — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f3033cc6-329e-4e31-8312-48541db76271/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-504.3M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-008238 |
| FY 2021 | $-401.5M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003472 |
| FY 2020 | $-244.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-006983 |
| FY 2019 | $-259.4M | 2019-01-01 – 2019-12-31 | evidence 0000850261-20-000027 |
| FY 2018 | $-150.4M | 2018-01-01 – 2018-12-31 | evidence 0000850261-19-000002 |
| FY 2017 | $25.3M | 2017-01-01 – 2017-12-31 | evidence 0000850261-18-000013 |
| FY 2016 | $-96.8M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004944 |
| FY 2015 | $-74.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014768 |
| FY 2014 | $-34.7M | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001681 |
| FY 2013 | $-42.5M | 2006-01-26 – 2014-03-31 | evidence 0001193125-14-199060 |
| FY 2012 | $-13.5M | 2006-01-25 – 2013-03-31 | evidence 0001193125-13-222066 |
| FY 2011 | $-7.0M | 2006-01-25 – 2012-03-31 | evidence 0001193125-12-234125 |
| FY 2010 | $-1.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-144051 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SORRENTO THERAPEUTICS, INC. — all facts · Revenue · Net Income